Clinical significance of EphA2 expression in squamous-cell carcinoma of the head and neck.
about
High EphA2 protein expression in renal cell carcinoma is associated with a poor disease outcome.Lack of ephrin receptor A1 is a favorable independent prognostic factor in clear cell renal cell carcinoma.Ephrin type‑A receptor 2 regulates sensitivity to paclitaxel in nasopharyngeal carcinoma via the phosphoinositide 3‑kinase/Akt signalling pathwayEphA2 is a critical oncogene in melanoma.EphA2 silencing in nasopharyngeal carcinoma leads to decreased proliferation, invasion and increased sensitization to paclitaxelNovel anti-EPHA2 antibody, DS-8895a for cancer treatment.Increased expression of metadherin protein predicts worse disease-free and overall survival in laryngeal squamous cell carcinoma.Downregulation of EphA2 expression suppresses the growth and metastasis in squamous-cell carcinoma of the head and neck in vitro and in vivo.Immunohistochemical demonstration of EphA2 processing by MT1-MMP in invasive cutaneous squamous cell carcinoma.KDM5B overexpression predicts a poor prognosis in patients with squamous cell carcinoma of the head and neck.Targeting EphA2-Sam and Its Interactome: Design and Evaluation of Helical Peptides Enriched in Charged Residues.MiR-98 inhibits malignant progression via targeting MTDH in squamous cell carcinoma of the head and neck.Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.Prognostic role of EphA2 in various human carcinomas: a meta-analysis of 23 related studies.
P2860
Q33844126-2C6B87F3-F8A0-46C2-A78D-1DCBBB4CD6C0Q33904883-07E561FF-7365-4B3D-97FD-3BE400A5B148Q34673530-C659B28F-CBE2-4D8D-9CBF-F2FE1807FA14Q35218960-E4E565DE-B329-4F97-9D03-7D69AE948D8AQ36905288-3365B76B-22AF-4CC0-BD43-307AAFFEF7F2Q37473163-C0FF99A6-E1BC-40BF-8609-BAFBC41029B3Q38398311-33FB7771-1CB5-47E1-AC48-EB9C8CA4AA7AQ39442560-ED7A782B-BE5E-4ED2-B3BD-62D8F3115E9DQ40365068-00B92887-CD53-4B5D-A2C3-BF589FF484FDQ47097815-559F07C7-DAC6-4CD9-A914-9E4C250F1A15Q48966042-CA91587E-51E0-48C7-8133-B68FA07CCBACQ49204870-5CB71FED-7909-4B40-8E10-E71240D46040Q54300030-A811EEA3-D286-46BE-B92D-6E6C551B1CC5Q55070097-67ED0D84-86EF-4351-9C56-AED654BA3986
P2860
Clinical significance of EphA2 expression in squamous-cell carcinoma of the head and neck.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Clinical significance of EphA2 ...... arcinoma of the head and neck.
@en
Clinical significance of EphA2 ...... arcinoma of the head and neck.
@nl
type
label
Clinical significance of EphA2 ...... arcinoma of the head and neck.
@en
Clinical significance of EphA2 ...... arcinoma of the head and neck.
@nl
prefLabel
Clinical significance of EphA2 ...... arcinoma of the head and neck.
@en
Clinical significance of EphA2 ...... arcinoma of the head and neck.
@nl
P2093
P2860
P1476
Clinical significance of EphA2 expression in squamous-cell carcinoma of the head and neck
@en
P2093
Changyun Yu
Donghai Huang
Shuai Zhang
Xiaojuan Zhou
Yongquan Tian
Yuanzheng Qiu
P2860
P2888
P304
P356
10.1007/S00432-010-0936-2
P50
P577
2010-07-08T00:00:00Z